Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Japanese Patients With Active Crohn's Disease
jRCT2080220544Phase 2
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide in Crohn's disease (3 arms), sponsored by AstraZeneca.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080220544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220544.